Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University Hospital

Last updated: September 16, 2024
Sponsor: Sohag University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Scar Tissue

Hepatic Fibrosis

Hyponatremia

Treatment

abdominal ultrasound

Clinical Study ID

NCT06601829
soh-Med-24-08-01MS
  • All Genders

Study Summary

polycystic kidney disease is aherditary disorder characterized by the formation of numerous fluid filled cysts in the kidneys which can lead to progressive renal impairment PKDencompasses aspectrum of disorders with autosomal dominant polycystic kidneydisease and autosomal recessive polycystic kidney disease being the two main types

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • pediatric patients aged 0-18 years both male and female patients

Exclusion

Exclusion Criteria:

  • patients whose guardians dont provide informed consent patients who are notcomplient with follow up vists and data collection protocols

Study Design

Total Participants: 30
Treatment Group(s): 1
Primary Treatment: abdominal ultrasound
Phase:
Study Start date:
August 01, 2024
Estimated Completion Date:
August 01, 2025

Connect with a study center

  • Sohag university Hospital

    Sohag,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.